Covid-19: India orders 300 million doses of unapproved vaccine
The central government has paid advance to local firm Biological-E even though its vaccine is still undergoing phase-3 clinical trials
Stay updated with breaking news from Biological E. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The central government has paid advance to local firm Biological-E even though its vaccine is still undergoing phase-3 clinical trials
A look at the biggest Covid-19 developments of the day.
NEW DELHI â In another landmark move in the fight against Covid-19 pandemic, the Central government has booked 300 million doses of another Made-in-India vaccine to be manufactured by Hyderabad-based Biological-E's Covid vaccine, which is still in final phase of clinical trials. Biological-E's vaccine is currently in Phase-3 clinical trials after showing promising results in Phase 1 and 2, and it is likely to be available in the market in next few months, said a Ministry of Health and Family Welfare (MoHFW) statement. The Ministry is learnt to have made an advance payment of Rs 1,500 ...
The vaccines will be manufactured and stockpiled by Biological-E from August-December 2021
भारत से कोरोना वायरस की दूसरी लहर का प्रकोप भले ही कम हो रहा हो लेकिन टीकाकरण की गति अब भी Government booked 30 crore doses corona vaccine from Biological-E will give 1500 crore rupees, Hindi News - Hindustan